One I am eyeing right now is XKEM looks like all but 2 trades so far have been buys and is currently trading at .024 check it out.
Posted by IROC on :
.027 now
Posted by Wallace#1 on :
Have been in this one for a while. Have had a buy in at .015, hoping I could get more...does not look promising at that pps.
Posted by MxPx on :
Hmmmm I wonder if .030 is all we are gonna get out of XKEM today?
Posted by Wallace#1 on :
quote:Originally posted by MxPx: Hmmmm I wonder if .030 is all we are gonna get out of XKEM today?
The way it jumped, I thought some PR might have been released but couldn't find anything. Maybe one is coming?
Posted by MxPx on :
quote:Originally posted by Wallace#1: The way it jumped, I thought some PR might have been released but couldn't find anything. Maybe one is coming?
Possibly? All I know she came up on my radar as having mostly all buys and higher than average volume. But I guess we will wait and see what it does.
Posted by EverGreen on :
nice volume today on no news (yet)
Posted by EverGreen on :
... and here is the news
NEW BRUNSWICK, N.J., Feb 17, 2005 (BUSINESS WIRE) -- Xechem International Inc. (XKEM) today announced significant progress in its development efforts for NICOSAN(TM)/ HEMOXIN(TM), a natural product extract which shows promise in the treatment of Sickle Cell Disease (SCD). Xechem has an exclusive world-wide license for the development and sale of NICOSAN(TM)/ HEMOXIN(TM) from the National Institute for Pharmaceutical Research and Development (NIPRD), Abuja, government of Nigeria, which holds the patent.
Posted by GHOSTRADER on :
not running yet u think it will on that news ?
Posted by Jong on :
Starting to run now and volume is picking up. .028 x .029 volume about 1,600,000. Jonathan
Posted by Junky on :
it wasn't exactly stellar news, but it eased my concerns about inactivity. i am looking forward to the upcoming months. this was a steal, thanks to the ridiculously stupid nature of reverse splits.
Posted by EverGreen on :
great news - only the stock in portfolio is worth $19m !!!
-- Xechem International Inc. (XKEM) today announced that its corporate spinoff, Ceptor Corporation, has successfully completed a $12,000,000 private offering and is now an independent company whose shares are traded on the NASD over the counter bulletin board, under the symbol CEPO. Ceptor is engaged in the development of technology for the treatment of neuromuscular and neurodegenerative diseases such as muscular dystrophy, multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS). As a result of the transaction, Xechem continues to hold 3,386,563 shares of Ceptor or approximately 14% on a fully diluted basis, assuming full conversion of all shares sold in the private placement and other exercises and conversions. In addition, pursuant to Xechem's spin off agreement with Ceptor, Xechem has been paid $1,279,125 by Ceptor and is entitled to receive an additional $720,875 from future Ceptor financings in redemption of Ceptor stock held by Xechem, following which, the redemption pursuant to the spin off agreement will be complete. The proceeds of Xechem's sale of Ceptor's stock, pursuant to the redemption provision of the spin off agreement, are being used for Xechem's internal working capital purposes. Ceptor stock closed at $5.80 per share on Tuesday, February 22, 2005.